Evidence map›Paper›PMID 35370628›Full record

ReviewFrontiers in pharmacology2021

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.

Xiaopeng Ai, Peiling Yu, Lixia Peng, Liuling Luo, Jia Liu, Shengqian Li, Xianrong Lai, Fei Luan, Xianli Meng

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 5 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 5 syntheses or guidelines pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Review
  9. SIRT3-Dependent Actions of Berberine: From Molecular Therapies to Toxicity.Journal of biochemical and molecular toxicology · 2026
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Bioactive spectrum of goji berries (Food chemistry: X · 2026
    Review
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaopeng AiSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Peiling YuDepartment of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Lixia PengSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Liuling LuoSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jia LiuSchool of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Shengqian LiDepartment of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Xianrong LaiSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Fei LuanSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xianli MengSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Chengdu University of Traditional Chinese Medicine · CNAffiliated Hospital of North Sichuan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Chinese medicine plays a significant role in the treatment of various diseases and has attracted increasing attention for clinical applications. Vascular diseases affecting vasculature in the heart, cerebrovascular disease, atherosclerosis, and diabetic complications have compromised quality of life for affected individuals and increase the burden on health care services. Berberine, a naturally occurring isoquinoline alkaloid form

Indexed as

berberinecardiovascular diseasecerebrovascular diseasediabetes mellituspharmacokinetics

Identifiers

PMID35370628
PMCPMC8964367
OpenAlexW3211775389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.